Equity Insight – Interview with CEO of Algernon Pharmaceuticals

Today we have the CEO of Algernon Pharmaceuticals (CSE: AGN) (OTCQB: AGNPF) Mr. Christopher Moreau sitting down with us for an exclusive interview regarding the company’s operations surrounding Covid-19.EI) Mr. Moreau, for investors that are not very familiar with Algernon Pharmaceuticals, could you tell us the vision of Algernon and how it all began?

 

click below to view the articles
Share via
Copy link
Powered by Social Snap